Video
1 Sep 2026

Strategic Partnership MOU Signing Ceremony | Prestige Biologics & Charles River

At BIO USA 2026, Prestige Biopharma Group signed a Strategic Memorandum of Understanding (MOU) with Charles River Laboratories.

The partnership connects capabilities across the biologics development lifecycle—from antibody drug development and preclinical services to analytical testing, process development, and GMP manufacturing. By linking development-stage programs with manufacturing opportunities, the collaboration aims to expand global CDMO business opportunities.

Content provided by our supplier

PRESTIGE BIOLOGICS

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis

Other Content from PRESTIGE BIOLOGICS (6)

  • News Flexible CDMO/CMO Service by dynamics of each plant: Prestige Biologics

    Prestige Biologics operates state-of-the-art Drug Substance (DS) production facilities that effectively support both Upstream and Downstream processes. Our GMP facilities meet the most stringent global standards, contributing to the ecosystem of biopharmaceutical supply. Prestige Biologics offers customers production capabilities for monoclonal antibodies (mAb), bi-specific antibodies (bsAb), multi-antibodies, fusion antibodies, and recombinant proteins. We have accumulated extensive experience to ensure optimal production efficiency.

    Drawing on our experience in process development and commercial production of several #biosimilars and #biologics pharmaceuticals in 2,000 L Single-Use Bioreactors, we are committed to sharing our expertise with our customers.

    We hope to share our story of providing flexible and reliable Contract Manufacturing Organization (CMO) services for biopharmaceuticals at CPHI.
     

  • Brochure Integrated Biologics CDMO Services

    Prestige Biologics is a biologics-focused CDMO providing drug substance (DS) and drug product (DP) manufacturing services from technology transfer through commercial supply. Our capabilities include GMP manufacturing, analytical testing, stability studies, clinical trial packaging, and storage solutions, supported by a total manufacturing capacity of 154,000 L and integrated operations at a single site.
  • Video Prestige Biologics | Vision. Innovation. Excellence.

    Prestige Biologics presents our brand film. Discover our vision, innovation, and excellence as a trusted global CDMO.
  • Video Factory Drone View | Global CDMO Prestige Biologics

    Experience the inside of Prestige Biologics, a state-of-the-art biopharmaceutical manufacturing facility. Through this drone tour, discover how innovation, scale, and quality come together to deliver world-class CDMO services.
  • Brochure Aseptic Fill-Finish & Drug Product Manufacturing Services

    Prestige Biologics provides integrated aseptic manufacturing services for biologics through clinical and commercial manufacturing. Our capabilities include drug substance manufacturing, aseptic fill-finish, analytical testing, packaging, labeling, clinical supply support, and commercial manufacturing in GMP-compliant facilities.
  • Brochure Clinical Packaging & Distribution Services

    Prestige Biologics provides clinical packaging and distribution services for investigational and commercial pharmaceuticals. Our capabilities include labeling and re-labeling, secondary packaging, IP code management, GDP-compliant storage, and temperature-controlled distribution, supported by GMP-compliant operations and automated warehouse systems.